Download PDF
CC BY-NC-ND 4.0 · Asian J Neurosurg 2020; 15(02): 349-353
DOI: 10.4103/ajns.AJNS_364_19
Original Article

Two-staged approach for giant hypervascular meningioma resection

Ahmed Ansari
Department of Neurosurgery, UPUMS, Etawah, Uttar Pradesh
,
Sadaf Riyaz
1   Department of Microbiology, UPUMS, Etawah, Uttar Pradesh
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Introduction: Giant meningiomas represent very uncommon and challenging tumors. Surgical morbidity is high due to the difficult and complex approaches to devascularize these hypervascular lesions. In the present series, we demonstrate a two-staged approach for surgical resection of giant hypervascular meningiomas. Patients and Methods: Four such patients having giant hypervascular meningiomas between July 2017 and June 2019 were taken in the present study. There were two falco-tentorial, one anterior and middle parasagittal and falcine meningioma, and one sphenoid wing with convexity meningioma. Results: In the first stage, only the hypervascular bone was removed, and the dura was coagulated and excised. In the definitive stage, usually undertaken 5–8 days following the first surgery, the meningioma was excised, leading to Simpson's Grade 2 excision in two and Grade 3 excision in the remaining two patients. There was one mortality of a previously operated malignant meningioma (histopathologically proven), owing to a cardiac event in the patient, while the other three were discharged without any new neurologic deficit. Conclusion: Two-staged approach for giant meningiomas represents a safe and effective surgical management, tolerable for the patient and more comfortable for the neurosurgeon.

Key-words:

Giant meningioma - hypervascular - staged approach

Financial support and sponsorship

Nil.




Publication History

Received: 23 December 2019

Accepted: 25 February 2020

Article published online:
16 August 2022

© 2020. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Adegbite AB, Khan MI, Paine KW, Tan LK. The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 1983;58:51-6.
  • 2 Ildan F, Erman T, Göçer AI, Tuna M, Baǧdatoǧlu H, Cetinalp E, et al. Predicting the probability of meningioma recurrence in the preoperative and early postoperative period: A multivariate analysis in the midterm follow-up. Skull Base 2007;17:157-71.
  • 3 Hasseleid BF, Meling TR, Rønning P, Scheie D, Helseth E. Surgery for convexity meningioma: Simpson Grade I resection as the goal: Clinical article. J Neurosurg 2012;117:999-1006.
  • 4 Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957;20:22-39.
  • 5 Jung TY, Jung S, Shin SR, Moon KS, Kim IY, Park SJ, et al. Clinical and histopathological analysis of cystic meningiomas. J Clin Neurosci 2005;12:651-5.
  • 6 Ayerbe J, Lobato RD, de la Cruz J, Alday R, Rivas JJ, Gómez PA, et al. Risk factors predicting recurrence in patients operated on for intracranial meningioma. A multivariate analysis. Acta Neurochir (Wien) 1999;141:921-32.
  • 7 Kolles H, Niedermayer I, Schmitt C, Henn W, Feld R, Steudel WI, et al. Triple approach for diagnosis and grading of meningiomas: Histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. Acta Neurochir (Wien) 1995;137:174-81.
  • 8 Mattei TA, Mattei JA, Ramina R, Aguiar PH, Plese JP, Marino R. Edema and malignancy in meningiomas. Clin 2005;60:201-206.
  • 9 Mantle RE, Lach B, Delgado MR, Baeesa S, Bélanger G. Predicting the probability of meningioma recurrence based on the quantity of peritumoral brain edema on computerized tomography scanning. J Neurosurg 1999;91:375-83.
  • 10 Mawrin C, Sasse T, Kirches E, Kropf S, Schneider T, Grimm C, et al. Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas. Clin Cancer Res 2005;11:4074-82.
  • 11 Schiffer D, Ghimenti C, Fiano V. Absence of histological signs of tumor progression in recurrences of completely resected meningiomas. J Neurooncol 2005;73:125-30.
  • 12 Voß KM, Spille DC, Sauerland C, Suero Molina E, Brokinkel C, Paulus W, et al. The Simpson grading in meningioma surgery: Does the tumor location influence the prognostic value? J Neurooncol 2017;133:641-51.
  • 13 Schipmann S, Schwake M, Sporns PB, Voß KM, Sicking J, Spille DC, et al. Is the Simpson Grading System Applicable to Estimate the Risk of Tumor Progression After Microsurgery for Recurrent Intracranial Meningioma? World Neurosurg 2018;119:e589-e597.
  • 14 Otero-Rodriguez A, Tabernero MD, Munoz-Martin MC, Sousa P, Orfao A, Pascual-Argente D, et al. Re-Evaluating Simpson Grade I, II, and III Resections in Neurosurgical Treatment of World Health Organization Grade I Meningiomas. World Neurosurg 2016;96:483-8.
  • 15 Meling TR, Da Broi M, Scheie D, Helseth E. Meningiomas: Skull base versus non-skull base. Neurosurg Rev 2019;42:163-73.
  • 16 Terrier LM, Bernard F, Fournier HD, Morandi X, Velut S, Hénaux PL, et al. Spheno-Orbital Meningiomas Surgery: Multicenter Management Study for Complex Extensive Tumors. World Neurosurg 2018;112:e145-56.